GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2018-04-12: Form 6-K; Period of report 2018-04-12; Description DIRECTOR/PDMR SHAREHOLDING; Document a7705k.htm.
- 2018-04-03: Form 6-K; Period of report 2018-04-03; Description TOTAL VOTING RIGHTS; Document a6917j.htm.
- 2018-03-29: Form 6-K; Period of report 2018-03-29; Description NOTICE OF AGM; Document a4427j.htm.
- 2018-03-27: Form 6-K; Period of report 2018-03-27; Description GSK AGREES TO ACQUIRE CH BUSINESS FROM NOVARTIS; Document a1115j.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2018-04-12 | 6-K | 2018-04-12 | DIRECTOR/PDMR SHAREHOLDING | a7705k.htm |
| 2018-04-03 | 6-K | 2018-04-03 | TOTAL VOTING RIGHTS | a6917j.htm |
| 2018-03-29 | 6-K | 2018-03-29 | NOTICE OF AGM | a4427j.htm |
| 2018-03-27 | 6-K | 2018-03-27 | GSK AGREES TO ACQUIRE CH BUSINESS FROM NOVARTIS | a1115j.htm |
| 2018-03-23 | 6-K | 2018-03-23 | VIIV - CHMP POSITIVE OPINION FOR JULUCA IN EUROPE | a7722i.htm |
| 2018-03-23 | 6-K | 2018-03-23 | UPDATE REGARDING PFIZER INC. CONSUMER HEALTHCARE | a7252i.htm |
| 2018-03-23 | 6-K | 2018-03-23 | SHINGRIX APPROVED IN EUROPE AND JAPAN | a7192i.htm |
| 2018-03-19 | 6-K | 2018-03-19 | GSK 2017 FORM 20-F | a0670i.htm |
| 2018-03-13 | 6-K | 2018-03-13 | ANNUAL FINANCIAL REPORT | a5967h.htm |
| 2018-03-12 | 6-K | 2018-03-12 | DIRECTOR/PDMR SHAREHOLDING | a4700h.htm |
| 2018-03-05 | 6-K | 2018-03-05 | VIIV HEALTHCARE ANNOUNCES NEW DOLUTEGRAVIR DATA | a7508g.htm |
| 2018-03-05 | 6-K | 2018-03-05 | NUCALA OSMO STUDY PRESENTED AT AAAAI-WAO CONGRESS | a7294g.htm |
| 2018-03-05 | 6-K | 2018-03-05 | DIRECTOR/PDMR SHAREHOLDING | a7064g.htm |
| 2018-03-02 | 6-K | 2018-03-02 | DIRECTOR/PDMR SHAREHOLDING | a5680g.htm |
| 2018-03-01 | 6-K | 2018-03-01 | TOTAL VOTING RIGHTS | a4038g.htm |
| 2018-02-22 | 6-K | 2018-02-22 | DIRECTOR/PDMR SHAREHOLDING | a7086f.htm |
| 2018-02-20 | 6-K | 2018-02-20 | DIRECTOR/PDMR SHAREHOLDING | a4151fa.htm |
| 2018-02-20 | 6-K | 2018-02-20 | DIRECTOR/PDMR SHAREHOLDING | a4144f.htm |
| 2018-02-20 | 6-K | 2018-02-20 | DIRECTOR/PDMR SHAREHOLDING | a4150f.htm |
| 2018-02-20 | 6-K | 2018-02-20 | DIRECTOR/PDMR SHAREHOLDING | a3235f.htm |
| 2018-02-16 | 6-K | 2018-02-16 | DIRECTOR/PDMR SHAREHOLDING | a1949f.htm |
| 2018-02-16 | 6-K | 2018-02-16 | DIRECTOR/PDMR SHAREHOLDING | a1944f.htm |
| 2018-02-16 | 6-K | 2018-02-16 | DIRECTOR/PDMR SHAREHOLDING | a1495f.htm |
| 2018-02-15 | 6-K | 2018-02-15 | DIRECTOR/PDMR SHAREHOLDING | a0678f.htm |
| 2018-02-15 | 6-K | 2018-02-15 | DIRECTOR/PDMR SHAREHOLDING | a0668f.htm |
| 2018-02-15 | 6-K | 2018-02-15 | DIRECTOR/PDMR SHAREHOLDING | a0671f.htm |
| 2018-02-14 | 6-K | 2018-02-14 | GSK SUBMITS LANDMARK IMPACT DATA - TRELEGY ELLIPTA | a8595e.htm |
| 2018-02-13 | 6-K | 2018-02-13 | DIRECTOR/PDMR SHAREHOLDING | a7930e.htm |
| 2018-02-12 | 6-K | 2018-02-12 | DIRECTOR/PDMR SHAREHOLDING | a6264e.htm |
| 2018-02-12 | 6-K | 2018-02-12 | DIRECTOR/PDMR SHAREHOLDING | a6113e.htm |
| 2018-02-08 | 6-K | 2018-02-08 | VIIV HEALTHCARE LAUNCHES NEW TWO-DRUG HIV STUDY | a3089e.htm |
| 2018-02-08 | 6-K | 2018-02-08 | VIIV FILES PATENT INFRINGEMENT LITIGATION | a2501e.htm |
| 2018-02-07 | 6-K | 2018-02-07 | FINAL RESULTS | a2006e.htm |
| 2018-02-07 | 6-K | 2018-02-07 | DIRECTOR/PDMR SHAREHOLDING | a2104e.htm |
| 2018-02-07 | 6-K | 2018-02-07 | GSKS BEXSERO FDA BREAKTHROUGH THERAPY DESIGNATION | a1656e.htm |
| 2018-02-01 | 6-K | 2018-02-01 | TOTAL VOTING RIGHTS | a6522d.htm |
| 2018-01-26 | 6-K | 2018-01-26 | GSKS SHINGRIX POSITIVE CHMP OPINION IN EUROPE | a0807d.htm |
| 2018-01-26 | 6-K | 2018-01-26 | GSKS RELVAR ELLIPTA POSITIVE CHMP OPINION | a9863c.htm |
| 2018-01-23 | 6-K | 2018-01-23 | DIRECTOR/PDMR SHAREHOLDING | a7050c.htm |
| 2018-01-19 | 6-K | 2018-01-19 | DIRECTOR/PDMR SHAREHOLDING | a4508c.htm |
| 2018-01-19 | 6-K | 2018-01-19 | DIRECTOR/PDMR SHAREHOLDING | a4506c.htm |
| 2018-01-16 | 6-K | 2018-01-16 | DIRECTOR/PDMR SHAREHOLDING | a0620c.htm |
| 2018-01-16 | 6-K | 2018-01-16 | DIRECTOR/PDMR SHAREHOLDING | a9407b.htm |
| 2018-01-16 | 6-K | 2018-01-16 | DIRECTOR/PDMR SHAREHOLDING | a9404b.htm |
| 2018-01-16 | 6-K | 2018-01-16 | DIRECTOR/PDMR SHAREHOLDING | a8595b.htm |
| 2018-01-16 | 6-K | 2018-01-16 | DIRECTOR/PDMR SHAREHOLDING | a9382b.htm |
| 2018-01-16 | 6-K | 2018-01-16 | DIRECTOR/PDMR SHAREHOLDING | a8579b000.htm |
| 2018-01-11 | 6-K | 2018-01-11 | DIRECTOR/PDMR SHAREHOLDING | a6597b.htm |
| 2018-01-02 | 6-K | 2018-01-02 | DIRECTOR SHAREHOLDING | a7427a.htm |
| 2018-01-02 | 6-K | 2018-01-02 | TOTAL VOTING RIGHTS | a7418a.htm |